[Celiac disease, histocompatibility antigens and immunologic status]

Area of Science:

• Immunogenetics
• Clinical Immunology

Context:

• Celiac disease is an autoimmune disorder triggered by gluten ingestion.
• Understanding the genetic and immunologic factors influencing celiac disease is crucial for diagnosis and management.

Purpose:

• To investigate immunologic and genetic markers, specifically blood group and histocompatibility antigens, in celiac disease patients undergoing treatment.
• To compare these markers between celiac patients and a healthy control group.

Summary:

• Immunologic studies (leukocytes, lymphocytes, immunoglobulins, complement) showed no significant differences between treated celiac patients and controls, possibly due to ongoing treatment.
• Analysis of ABO and Rh blood groups indicated an increased prevalence of A and B groups among patients, suggesting potential protection.
• Specific human leukocyte antigen (HLA) profiles, such as the low presence of A9, B5, B7, BW16, may confer protection, while the presence of A1, B8, DR3, DR7 indicates a higher risk for celiac disease.

Impact:

• These findings highlight the association between specific histocompatibility antigens and susceptibility to celiac disease.
• The study contributes to understanding the genetic predisposition and immunologic underpinnings of celiac disease.
• Identifies potential genetic markers that could aid in risk assessment for celiac disease.